CAMH study reveals a new target for developing treatments for depression
TORONTO, March 6, 2019 – A new CAMH study shows for the first time that people experiencing clinical depression have higher levels of a brain protein called MAO-B. The finding – published online today in JAMA Psychiatry – opens the door to a new area of exploration for developing depression treatments. Depression affects an […]
